WNT3A and bone sarcoma: Stimulation of the Wnt/β-catenin by Wnt3a markedly triggered c-Myc expression in bone sarcoma cells, whereas downregulation of β-catenin/TCF signaling resulted in reduction of c-Myc and cyclin D1 levels and decreased cell proliferation.